US Patent:
20190083622, Mar 21, 2019
Inventors:
Joshua Raderman - Boulder CO, US
Kevin H. Fortin - Williams IN, US
International Classification:
A61K 47/06
A61K 31/047
A61K 31/192
A61K 31/352
A61K 47/44
A61K 9/107
Abstract:
A cannabinoid formulation including a carbon-based antioxidant. Preferably, the formulation is a colloid including C60 and cannabinoids in a lipid-based excipient. The formulation improves shelf life of cannabinoids and inhibits degradation of the cannabinoids over time due to oxidation. The present invention further sequesters, neutralizes, or inhibits, oxidative free radicals in vivo. The action of the C60 prepares the body on a cellular level to enhance the bioactivity of the cannabinoids. The function of the C60 in combination with cannabinoids greatly reduces inflammation, improves metabolism, inhibits free radical degradation of telomeres, and has many other health benefits. The C60 in combination with the cannabinoids enhances the function of the cannabinoids by improving latency and efficacy in vivo.